Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data.

Lee AY, Butt T, Chew E, Agron E, Clemons TE, Egan CA, Lee CS, Tufail A; UK EMR AMD Research Group.

Br J Ophthalmol. 2018 Apr;102(4):465-472. doi: 10.1136/bjophthalmol-2017-310939. Epub 2017 Aug 23.

PMID:
28835423
2.

Agent-Based Modeling of Chronic Diseases: A Narrative Review and Future Research Directions.

Li Y, Lawley MA, Siscovick DS, Zhang D, Pagán JA.

Prev Chronic Dis. 2016 May 26;13:E69. doi: 10.5888/pcd13.150561. Review.

3.

Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration.

Brilliant MH, Vaziri K, Connor TB Jr, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW Jr, Moshfeghi AA, Moshfeghi DM, Fini ME, McKay BS.

Am J Med. 2016 Mar;129(3):292-8. doi: 10.1016/j.amjmed.2015.10.015. Epub 2015 Oct 30.

4.

Cost-effectiveness of anti-oxidant vitamins plus zinc treatment to prevent the progression of intermediate age-related macular degeneration. A Singapore perspective.

Saxena N, George PP, Heng BH, Lim TH, Yong SO.

Indian J Ophthalmol. 2015 Jun;63(6):516-23. doi: 10.4103/0301-4738.158533.

5.

Agent-based modeling of noncommunicable diseases: a systematic review.

Nianogo RA, Arah OA.

Am J Public Health. 2015 Mar;105(3):e20-31. doi: 10.2105/AJPH.2014.302426. Epub 2015 Jan 20. Review.

6.

An Agent-Based Modeling Template for a Cohort of Veterans with Diabetic Retinopathy.

Day TE, Ravi N, Xian H, Brugh A.

PLoS One. 2013 Jun 21;8(6):e66812. doi: 10.1371/journal.pone.0066812. Print 2013.

7.

The cost-effectiveness of Welcome to Medicare visual acuity screening and a possible alternative welcome to medicare eye evaluation among persons without diagnosed diabetes mellitus.

Rein DB, Wittenborn JS, Zhang X, Hoerger TJ, Zhang P, Klein BE, Lee KE, Klein R, Saaddine JB.

Arch Ophthalmol. 2012 May;130(5):607-14. doi: 10.1001/archopthalmol.2011.1921.

8.

Economic analysis of nutrition interventions for chronic disease prevention: methods, research, and policy.

Wong JB, Coates PM, Russell RM, Dwyer JT, Schuttinga JA, Bowman BA, Peterson SA.

Nutr Rev. 2011 Sep;69(9):533-49. doi: 10.1111/j.1753-4887.2011.00412.x.

9.

The potential cost-effectiveness of amblyopia screening programs.

Rein DB, Wittenborn JS, Zhang X, Song M, Saaddine JB; Vision Cost-effectiveness Study Group.

J Pediatr Ophthalmol Strabismus. 2012 May-Jun;49(3):146-55; quiz 145, 156. doi: 10.3928/01913913-20110823-02. Epub 2011 Aug 30.

10.

The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.

Rein DB, Wittenborn JS, Zhang X, Allaire BA, Song MS, Klein R, Saaddine JB; Vision Cost-Effectiveness Study Group.

Health Serv Res. 2011 Oct;46(5):1534-61. doi: 10.1111/j.1475-6773.2011.01263.x. Epub 2011 Apr 14. Review.

11.
12.

Lifestyle exposures and eye diseases in adults.

Klein BE, Klein R.

Am J Ophthalmol. 2007 Dec;144(6):961-969. Epub 2007 Oct 18. Review.

Supplemental Content

Support Center